| MICAKINE Xyphos Biosciences, Inc.
98280611 21 Nov 2023 | on 28 Oct 2024 | Biological preparations for the treatment of cancer or viral-infected ... Class 005 Class 005 Pharmaceutical Products Biological preparations for the treatment of cancer or viral-infected cells | | | CONVERTIBLECAR Xyphos Biosciences, Inc.
98280616 21 Nov 2023 | on 28 Oct 2024 | Pharmaceuticals in the nature of biologic agents for adoptive cellular... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals in the nature of biologic agents for adoptive cellular therapy | | | XYPHOS Xyphos Biosciences, Inc.
98280623 21 Nov 2023 | on 28 Oct 2024 | Biological preparations for treatment of cancer and viral-infected cel... Class 005 Class 005 Pharmaceutical Products Biological preparations for treatment of cancer and viral-infected cells; pharmaceuticals in the nature of biologic agents for adoptive cellular therapy | | | ACCEL Xyphos Biosciences, Inc.
98280621 21 Nov 2023 | on 28 Oct 2024 | Biological preparations for treatment of cancer and viral-infected cel... Class 005 Class 005 Pharmaceutical Products Biological preparations for treatment of cancer and viral-infected cells; pharmaceuticals in the nature of biologic agents for adoptive cellular therapy | | | MICABODY Xyphos Biosciences Inc.
97832840 10 Mar 2023 | on 09 Aug 2024 | Protein compounds for treatment of cancer or viral-infected cells, nam... Class 001 Class 001 Chemical Products Protein compounds for treatment of cancer or viral-infected cells, namely, genetically-engineered protein compounds Class 005 Class 005 Pharmaceutical Products Protein compounds for targeting cancer or viral-infected cells, namely, genetically-engineered protein compounds for medical and scientific research | | | MICABODY Xyphos Biosciences Inc.
88599908 30 Aug 2019 | on 24 Apr 2023 | Protein compounds for targeting cancer or viral-infected cells, namely... Class 001 Class 001 Chemical Products MICA BODY Class 005 Class 005 Pharmaceutical Products Protein compounds for targeting cancer or viral-infected cells, namely, genetically-engineered protein compounds for medical and scientific research | | | CONVERTIBLECAR XYPHOS BIOSCIENCES INC.
87385108 24 Mar 2017 | on 15 Mar 2021 | Pharmaceuticals in the nature of biologic agents for adoptive cellular... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals in the nature of biologic agents for adoptive cellular therapy | | | MICABODY XYPHOS BIOSCIENCES INC.
86742840 31 Aug 2015 | on 21 Oct 2019 | Protein compounds for treatment of cancer or viral-infected cells, nam... Class 001 Class 001 Chemical Products Protein compounds for targeting cancer or viral-infected cells, namely, genetically-engineered protein compounds for medical and scientific research Class 005 Class 005 Pharmaceutical Products Protein compounds for treatment of cancer or viral-infected cells, namely, genetically-engineered protein compounds | | | MICAB XYPHOS BIOSCIENCES INC.
86754293 11 Sep 2015 | on 16 Apr 2018 | Protein compounds for treatment of cancer or viral-infected cells, nam... Class 001 Class 001 Chemical Products Protein compounds for treatment of cancer or viral-infected cells, namely, genetically-engineered protein compounds Class 005 Class 005 Pharmaceutical Products Protein compounds for targeting cancer or viral-infected cells, namely, genetically-engineered protein compounds for medical and scientific research | | 
